✦ LIBER ✦

High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis

✍ Scribed by Alexander Greb; Julia Bohlius; Sven Trelle; Daniel Schiefer; Carmino A. De Souza; Christian Gisselbrecht; Tanin Intragumtornchai; Ulrich Kaiser; Hanneke C. Kluin-Nelemans; Maurizio Martelli; Noel Jean Milpied; Gino Santini; Leo F. Verdonck; Umberto Vitolo; Guido Schwarzer; Andreas Engert

Book ID: 116395119
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 206 KB
Volume: 33
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2007.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial Treatment of Aggressive Lymphoma

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

✍ Milpied, Noel; Deconinck, Eric; Gaillard, Fanny; Delwail, Vincent; Foussard, Cha 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 121 KB

Standard chemotherapy is superior to hig

Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis

✍ Jing Wang; Ping Zhan; Jian Ouyang; Bing Chen; Rongfu Zhou; Yonggong Yang 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 219 KB

Stem Cells and Cancer Stem Cells, Volume

Stem Cells and Cancer Stem Cells, Volume 10 || High-Dose Chemotherapy with Autologous Stem Cell Support in the Treatment of Transformed B-Cell Non-Hodgkin’s Lymphomas

✍ Hayat, M.A. 📂 Article 📅 2013 🏛 Springer Netherlands ⚖ 147 KB

Modeled cost-effectiveness analysis of a

Modeled cost-effectiveness analysis of autologous haemopoietic stem cell transplantation compared with standard dose chemotherapy for relapsed, aggressive non-Hodgkin’s lymphoma

✍ J. Prajogo; P.A. Rowlings; A. Neil; J. Duke; H. Zhang; B. Stokes 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Treatment of relapsed or refractory Hodg

Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

High-dose chemotherapy and peripheral bl

High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers

✍ Weaver, C H; Schwartzberg, L; Zhen, B; Mangum, M; Leff, R; Tauer, K; Rosenberg, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB